Sign in

CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
270604595
Phone
781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-11 Rosen Howard B Director Grant or award · Stock Option (right to buy) +3,150 3,150
2024-06-11 Farid Marjan Director Grant or award +1,400 7,792
2024-06-11 Farid Marjan Director Grant or award · Stock Option (right to buy) +3,150 3,150
2024-06-11 PERRY GREGORY D Director Grant or award +1,400 10,894
2024-06-11 PERRY GREGORY D Director Grant or award · Stock Option (right to buy) +3,150 3,150
2024-06-11 Myers C. Daniel Director Grant or award +1,400 7,924
2024-06-11 Myers C. Daniel Director Grant or award · Stock Option (right to buy) +3,150 3,150
2024-06-11 KOVEN ANDREW I Director Grant or award +1,750 13,922
2024-06-11 KOVEN ANDREW I Director Grant or award · Stock Option (right to buy) +3,900 3,900
2024-06-11 Blumenkranz Mark S. Director Grant or award +1,400 13,091
2024-06-11 Blumenkranz Mark S. Director Grant or award · Stock Option (right to buy) +3,150 3,150
2024-05-31 Bazemore Todd SEE REMARKS Sale −2,093 $6.09 $13K 87,693
2024-05-31 Kharabi Darius CHIEF BUSINESS OFFICER Sale −231 $6.09 $1K 64,886
2024-05-31 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −1,786 $6.09 $11K 64,350
2024-05-31 Brazzell Romulus K SEE REMARKS Sale −2,002 $6.09 $12K 89,471
2024-05-31 Iwicki Mark T CHIEF EXECUTIVE OFFICER Sale −7,392 $6.09 $45K 278,923
2024-01-04 Trachtenberg Eric SEE REMARKS Grant or award +4,600 69,293
2024-01-04 Trachtenberg Eric SEE REMARKS Sale −1,227 $6.74 $8K 68,066
2024-01-04 Trachtenberg Eric SEE REMARKS Grant or award · Stock Option (right to buy) +20,500 20,500
2024-01-04 Kharabi Darius CHIEF BUSINESS OFFICER Grant or award +4,600 66,502

Page 4 of 12 · 236 trades